Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Ocd observed an increased number of complaints related to false positive and/or reactions containing haze in the anti-a and buffered gel microtubes used for reverse abo typing in the mts a/b/d monoclonal and reverse grouping card lots listed above. our investigation determined that the false positive reactions were due to broken gel beads in the microtubes of the mts cards.